Plan Design Committee agrees to implement Virta prescribing program; GLP‑1 policy emphasized
The Plan Design Committee agreed to implement Virta’s Responsible Prescribing Program to pursue cost savings and assist members transitioning off GLP‑1 medications; the committee also discussed renewal projections and deferred a final package until March.
The full story
Commission materials reported that the Plan Design Committee’s renewal projection fell from 12.3% to 9.6% and the committee discussed options including using calculated interest on unappropriated surplus and plan‑design changes to close the gap. The committee voted or agreed in committee to implement Virta’s Responsible Prescribing Program to achieve cost savings and to assist members in transitioning off glucagon‑like peptide‑1 (GLP‑1) medications.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
Keep reading for free
Create a free account to finish this story and see the video, transcript and key details.
Continue with GoogleContinue with emailAlready have an account? Log in